Public Profile

Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in 2017, the company has quickly established itself as a key provider of high-quality products, catering to both domestic and international markets. With a focus on innovation and sustainability, Solara offers a diverse range of APIs, particularly in the therapeutic areas of anti-infectives, cardiovascular, and central nervous system medications. The company’s commitment to quality and regulatory compliance has earned it a strong market position, with notable achievements in securing approvals from major global regulatory bodies. Solara's strategic operational regions extend across Asia, Europe, and the Americas, reinforcing its status as a trusted partner in the pharmaceutical supply chain.

DitchCarbon Score

How does Solara Active Pharma Sciences Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Solara Active Pharma Sciences Ltd's score of 21 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

15%

Let us know if this data was useful to you

Solara Active Pharma Sciences Ltd's reported carbon emissions

In 2024, Solara Active Pharma Sciences Ltd reported total carbon emissions of approximately 33,489,000 kg CO2e for Scope 1 and about 43,622,000 kg CO2e for Scope 2, resulting in a combined total of approximately 77,111,000 kg CO2e. This represents a significant increase from 2023, where emissions were approximately 11,168,000 kg CO2e for Scope 1 and about 43,425,000 kg CO2e for Scope 2, totalling around 54,593,000 kg CO2e. In 2022, the company recorded approximately 10,169,000 kg CO2e for Scope 1 and about 50,693,000 kg CO2e for Scope 2, leading to a total of around 60,862,000 kg CO2e. The data indicates a fluctuating trend in emissions over the past three years, with a notable increase in 2024. Solara has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company has reported emissions only for Scope 1 and Scope 2, with no data available for Scope 3 emissions. This limited disclosure suggests a need for enhanced transparency and commitment to comprehensive climate strategies in line with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
10,169,000
00,000,000
00,000,000
Scope 2
50,693,000
00,000,000
00,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Solara Active Pharma Sciences Ltd's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Solara Active Pharma Sciences Ltd is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Solara Active Pharma Sciences Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Parameds.com, Inc.

US
Financial intermediation services, except insurance and pension funding services (65)
Updated 24 days ago

Dipharma Francis S.r.l.

IT
Chemicals nec
Updated 24 days ago

Suven Life Sciences Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Anuh Pharma Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Morepen

IN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers